 Eric Thaler
Concepts (365)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sleep Apnea, Obstructive | 28 | 2022 | 228 | 9.790 |
Why?
| | Electric Stimulation Therapy | 16 | 2021 | 72 | 6.180 |
Why?
| | Implantable Neurostimulators | 7 | 2021 | 12 | 4.250 |
Why?
| | Hypoglossal Nerve | 11 | 2022 | 17 | 3.920 |
Why?
| | Robotic Surgical Procedures | 6 | 2020 | 74 | 2.960 |
Why?
| | Natural Orifice Endoscopic Surgery | 4 | 2020 | 34 | 2.030 |
Why?
| | Endoscopy | 14 | 2022 | 255 | 1.720 |
Why?
| | Robotics | 4 | 2015 | 85 | 1.540 |
Why?
| | Palate, Soft | 4 | 2021 | 11 | 1.430 |
Why?
| | Otorhinolaryngologic Surgical Procedures | 4 | 2020 | 37 | 1.140 |
Why?
| | Polysomnography | 10 | 2020 | 187 | 1.090 |
Why?
| | Tongue | 4 | 2021 | 81 | 1.040 |
Why?
| | Electronics, Medical | 5 | 2006 | 12 | 1.020 |
Why?
| | Otolaryngology | 2 | 2021 | 83 | 0.940 |
Why?
| | Airway Obstruction | 3 | 2022 | 167 | 0.880 |
Why?
| | Electrodes | 2 | 2021 | 88 | 0.870 |
Why?
| | Otorhinolaryngologic Diseases | 1 | 2021 | 16 | 0.850 |
Why?
| | Sinusitis | 5 | 2018 | 170 | 0.850 |
Why?
| | Airway Remodeling | 1 | 2021 | 63 | 0.830 |
Why?
| | Acromegaly | 1 | 2020 | 14 | 0.790 |
Why?
| | Palatine Tonsil | 1 | 2020 | 29 | 0.790 |
Why?
| | Treatment Outcome | 23 | 2021 | 9353 | 0.770 |
Why?
| | Internal Medicine | 1 | 2021 | 229 | 0.710 |
Why?
| | Sleep Apnea Syndromes | 2 | 2016 | 91 | 0.670 |
Why?
| | Tonsillectomy | 3 | 2014 | 75 | 0.670 |
Why?
| | Smell | 4 | 2005 | 110 | 0.660 |
Why?
| | Middle Aged | 36 | 2021 | 28659 | 0.660 |
Why?
| | Continuous Positive Airway Pressure | 4 | 2020 | 75 | 0.660 |
Why?
| | Pharynx | 2 | 2020 | 52 | 0.650 |
Why?
| | Biosensing Techniques | 5 | 2007 | 109 | 0.650 |
Why?
| | Prospective Studies | 18 | 2021 | 6422 | 0.640 |
Why?
| | Head and Neck Neoplasms | 3 | 2020 | 433 | 0.620 |
Why?
| | Humans | 73 | 2022 | 117633 | 0.580 |
Why?
| | Male | 49 | 2021 | 60403 | 0.550 |
Why?
| | Nose Neoplasms | 5 | 2008 | 22 | 0.530 |
Why?
| | Aged | 30 | 2021 | 20249 | 0.530 |
Why?
| | Uvula | 1 | 2012 | 2 | 0.480 |
Why?
| | Deglutition Disorders | 1 | 2014 | 133 | 0.470 |
Why?
| | Mouth | 3 | 2020 | 81 | 0.460 |
Why?
| | Cerebrospinal Fluid | 2 | 2005 | 93 | 0.460 |
Why?
| | Female | 40 | 2021 | 63247 | 0.450 |
Why?
| | Magnetic Resonance Imaging | 8 | 2015 | 3214 | 0.430 |
Why?
| | Zenker Diverticulum | 1 | 2010 | 5 | 0.410 |
Why?
| | Rhinitis | 4 | 2018 | 123 | 0.400 |
Why?
| | Electrodes, Implanted | 2 | 2021 | 110 | 0.390 |
Why?
| | Pattern Recognition, Automated | 2 | 2008 | 99 | 0.380 |
Why?
| | Sleep, REM | 2 | 2020 | 54 | 0.380 |
Why?
| | Biofilms | 2 | 2011 | 230 | 0.370 |
Why?
| | Amyloidosis | 2 | 2006 | 39 | 0.370 |
Why?
| | Colony Count, Microbial | 2 | 2008 | 84 | 0.370 |
Why?
| | Retrospective Studies | 16 | 2020 | 12331 | 0.360 |
Why?
| | Glossectomy | 3 | 2020 | 4 | 0.350 |
Why?
| | Volatile Organic Compounds | 3 | 2014 | 54 | 0.340 |
Why?
| | Learning Curve | 2 | 2020 | 68 | 0.340 |
Why?
| | Severity of Illness Index | 5 | 2021 | 2884 | 0.320 |
Why?
| | Parotid Diseases | 1 | 2006 | 4 | 0.310 |
Why?
| | Adult | 22 | 2020 | 32118 | 0.310 |
Why?
| | Submandibular Gland Diseases | 1 | 2006 | 3 | 0.310 |
Why?
| | Pseudomonas Infections | 1 | 2008 | 187 | 0.300 |
Why?
| | Gram-Negative Bacterial Infections | 1 | 2006 | 37 | 0.290 |
Why?
| | Clinical Chemistry Tests | 1 | 2005 | 11 | 0.290 |
Why?
| | Diagnostic Techniques and Procedures | 1 | 2005 | 18 | 0.280 |
Why?
| | Urinalysis | 1 | 2005 | 62 | 0.280 |
Why?
| | Pseudomonas aeruginosa | 1 | 2008 | 288 | 0.280 |
Why?
| | Respiration, Artificial | 4 | 2007 | 563 | 0.280 |
Why?
| | Biotechnology | 1 | 2005 | 43 | 0.280 |
Why?
| | Gram-Positive Bacterial Infections | 1 | 2006 | 64 | 0.280 |
Why?
| | Biomimetics | 1 | 2005 | 44 | 0.280 |
Why?
| | Pneumonia | 3 | 2005 | 578 | 0.270 |
Why?
| | Blood Chemical Analysis | 1 | 2005 | 95 | 0.270 |
Why?
| | Serum | 1 | 2005 | 65 | 0.270 |
Why?
| | Cerumen | 2 | 2014 | 2 | 0.270 |
Why?
| | Evaluation Studies as Topic | 3 | 2021 | 207 | 0.260 |
Why?
| | Cohort Studies | 6 | 2021 | 5112 | 0.260 |
Why?
| | Staphylococcus aureus | 1 | 2008 | 391 | 0.260 |
Why?
| | Specimen Handling | 1 | 2005 | 169 | 0.250 |
Why?
| | Staphylococcal Infections | 1 | 2008 | 334 | 0.250 |
Why?
| | Paranasal Sinuses | 2 | 2009 | 58 | 0.250 |
Why?
| | Larynx | 2 | 2020 | 46 | 0.240 |
Why?
| | Sleep Apnea, Central | 1 | 2022 | 11 | 0.240 |
Why?
| | Palate | 2 | 2020 | 33 | 0.240 |
Why?
| | Odorants | 3 | 2018 | 123 | 0.230 |
Why?
| | Predictive Value of Tests | 5 | 2021 | 1971 | 0.220 |
Why?
| | Epiglottis | 1 | 2021 | 3 | 0.220 |
Why?
| | Skull Base | 2 | 2012 | 37 | 0.210 |
Why?
| | Registries | 5 | 2021 | 1969 | 0.210 |
Why?
| | Cricoid Cartilage | 2 | 1997 | 13 | 0.210 |
Why?
| | Lymphoma, T-Cell | 1 | 2000 | 17 | 0.210 |
Why?
| | Macroglossia | 1 | 2020 | 1 | 0.200 |
Why?
| | Otolaryngologists | 1 | 2020 | 9 | 0.200 |
Why?
| | Video Recording | 2 | 2019 | 148 | 0.200 |
Why?
| | Laryngeal Neoplasms | 2 | 1998 | 38 | 0.190 |
Why?
| | Patient Satisfaction | 3 | 2019 | 617 | 0.190 |
Why?
| | Hypertrophy | 1 | 2020 | 122 | 0.190 |
Why?
| | Follow-Up Studies | 8 | 2018 | 4911 | 0.190 |
Why?
| | Siderosis | 1 | 1999 | 3 | 0.190 |
Why?
| | Hypopharynx | 1 | 2019 | 2 | 0.190 |
Why?
| | Hemangioma, Cavernous | 1 | 1999 | 17 | 0.190 |
Why?
| | Medical Staff, Hospital | 1 | 2020 | 76 | 0.190 |
Why?
| | History, 21st Century | 1 | 2020 | 195 | 0.190 |
Why?
| | Paranasal Sinus Neoplasms | 1 | 1999 | 17 | 0.190 |
Why?
| | Blood | 1 | 2000 | 101 | 0.190 |
Why?
| | Subarachnoid Hemorrhage | 1 | 1999 | 47 | 0.180 |
Why?
| | Deep Sedation | 1 | 2018 | 10 | 0.180 |
Why?
| | History, 20th Century | 1 | 2020 | 309 | 0.180 |
Why?
| | Body Mass Index | 2 | 2021 | 2076 | 0.180 |
Why?
| | Central Nervous System Diseases | 1 | 1999 | 64 | 0.180 |
Why?
| | Interprofessional Relations | 1 | 2021 | 276 | 0.180 |
Why?
| | Respiratory Tract Infections | 1 | 2002 | 297 | 0.180 |
Why?
| | Aged, 80 and over | 8 | 2018 | 6795 | 0.170 |
Why?
| | Product Surveillance, Postmarketing | 1 | 2019 | 69 | 0.170 |
Why?
| | Postoperative Complications | 4 | 2020 | 2113 | 0.170 |
Why?
| | Killer Cells, Natural | 1 | 2000 | 312 | 0.170 |
Why?
| | Bacterial Infections | 2 | 2011 | 220 | 0.170 |
Why?
| | Arytenoid Cartilage | 1 | 1997 | 6 | 0.170 |
Why?
| | Anesthesia, Local | 1 | 1997 | 15 | 0.170 |
Why?
| | Muscular Atrophy, Spinal | 1 | 1997 | 20 | 0.170 |
Why?
| | Skull Base Neoplasms | 2 | 2012 | 22 | 0.160 |
Why?
| | Respiratory System | 1 | 2018 | 142 | 0.160 |
Why?
| | Conscious Sedation | 1 | 1997 | 79 | 0.160 |
Why?
| | Patient Compliance | 1 | 2021 | 588 | 0.160 |
Why?
| | Gas Chromatography-Mass Spectrometry | 3 | 2014 | 145 | 0.150 |
Why?
| | Defibrillators, Implantable | 2 | 2018 | 408 | 0.150 |
Why?
| | Vestibular Nerve | 1 | 1996 | 17 | 0.150 |
Why?
| | Wound Healing | 1 | 2018 | 269 | 0.150 |
Why?
| | Prostheses and Implants | 1 | 2017 | 161 | 0.140 |
Why?
| | Electronics | 3 | 2007 | 69 | 0.140 |
Why?
| | Lymph Nodes | 2 | 2008 | 463 | 0.140 |
Why?
| | Feasibility Studies | 2 | 2018 | 766 | 0.140 |
Why?
| | Meniere Disease | 1 | 1996 | 28 | 0.140 |
Why?
| | Biopsy, Fine-Needle | 2 | 2006 | 66 | 0.140 |
Why?
| | Carcinoma | 1 | 1997 | 205 | 0.140 |
Why?
| | Imaging, Three-Dimensional | 1 | 2019 | 556 | 0.140 |
Why?
| | Preoperative Period | 1 | 2015 | 103 | 0.140 |
Why?
| | Breath Tests | 2 | 2005 | 92 | 0.130 |
Why?
| | Papilloma | 2 | 2008 | 51 | 0.130 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 365 | 0.130 |
Why?
| | Coronavirus Infections | 1 | 2020 | 353 | 0.130 |
Why?
| | Quality of Life | 3 | 2020 | 2354 | 0.130 |
Why?
| | Hearing | 1 | 1996 | 130 | 0.130 |
Why?
| | Postoperative Period | 1 | 2015 | 307 | 0.130 |
Why?
| | Surveys and Questionnaires | 3 | 2021 | 4842 | 0.130 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2014 | 129 | 0.130 |
Why?
| | Clinical Competence | 1 | 2021 | 948 | 0.130 |
Why?
| | Solid Phase Microextraction | 2 | 2014 | 8 | 0.130 |
Why?
| | Pharyngeal Diseases | 1 | 1993 | 16 | 0.130 |
Why?
| | Branchial Region | 1 | 1993 | 42 | 0.120 |
Why?
| | Anesthetics, Intravenous | 3 | 2012 | 34 | 0.120 |
Why?
| | Neoplasm Recurrence, Local | 4 | 2008 | 846 | 0.120 |
Why?
| | Time Factors | 3 | 2019 | 6906 | 0.120 |
Why?
| | Propofol | 3 | 2012 | 43 | 0.120 |
Why?
| | Hypoglossal Nerve Diseases | 1 | 2012 | 3 | 0.120 |
Why?
| | Carotid Artery, Internal, Dissection | 1 | 2012 | 8 | 0.120 |
Why?
| | Cysts | 1 | 1993 | 84 | 0.120 |
Why?
| | Chronic Disease | 5 | 2018 | 1674 | 0.120 |
Why?
| | Diagnosis, Differential | 4 | 2012 | 1405 | 0.120 |
Why?
| | Decision Making | 1 | 2000 | 806 | 0.120 |
Why?
| | Young Adult | 4 | 2015 | 11077 | 0.110 |
Why?
| | Diagnostic Errors | 1 | 2012 | 161 | 0.110 |
Why?
| | Brain Neoplasms | 1 | 1999 | 976 | 0.110 |
Why?
| | Wounds and Injuries | 1 | 2018 | 833 | 0.100 |
Why?
| | Anesthetics, Combined | 2 | 2000 | 8 | 0.100 |
Why?
| | Internship and Residency | 1 | 2020 | 1026 | 0.100 |
Why?
| | Bacteria | 2 | 2009 | 671 | 0.100 |
Why?
| | Papilloma, Inverted | 2 | 1999 | 3 | 0.100 |
Why?
| | Budesonide | 1 | 2010 | 89 | 0.090 |
Why?
| | Thyroglobulin | 1 | 2008 | 18 | 0.090 |
Why?
| | Mucus | 1 | 2009 | 56 | 0.090 |
Why?
| | Midazolam | 2 | 2000 | 51 | 0.090 |
Why?
| | Algorithms | 2 | 2008 | 1550 | 0.090 |
Why?
| | Human papillomavirus 6 | 1 | 2008 | 4 | 0.090 |
Why?
| | Germany | 2 | 2019 | 80 | 0.090 |
Why?
| | Carcinoma, Squamous Cell | 3 | 1999 | 597 | 0.090 |
Why?
| | Carcinoma, Papillary | 1 | 2008 | 75 | 0.090 |
Why?
| | Piperidines | 2 | 2000 | 174 | 0.090 |
Why?
| | Case-Control Studies | 3 | 2020 | 3269 | 0.080 |
Why?
| | Hydrazones | 1 | 2007 | 28 | 0.080 |
Why?
| | Oxygen | 1 | 2012 | 864 | 0.080 |
Why?
| | Obesity | 1 | 2021 | 2711 | 0.080 |
Why?
| | Operative Time | 2 | 2020 | 113 | 0.080 |
Why?
| | Pyridazines | 1 | 2007 | 57 | 0.080 |
Why?
| | Myocardial Revascularization | 1 | 2007 | 87 | 0.080 |
Why?
| | Hydrocortisone | 1 | 2010 | 332 | 0.080 |
Why?
| | Congo Red | 1 | 2006 | 9 | 0.080 |
Why?
| | Coloring Agents | 1 | 2006 | 77 | 0.080 |
Why?
| | Anti-Arrhythmia Agents | 1 | 2007 | 155 | 0.080 |
Why?
| | Thyroid Neoplasms | 1 | 2008 | 240 | 0.070 |
Why?
| | Amyloid | 1 | 2006 | 81 | 0.070 |
Why?
| | Transducers | 1 | 2005 | 32 | 0.070 |
Why?
| | Myocardial Ischemia | 1 | 2007 | 268 | 0.070 |
Why?
| | Tumor Cells, Cultured | 1 | 2007 | 920 | 0.070 |
Why?
| | Postoperative Care | 2 | 2016 | 229 | 0.070 |
Why?
| | Nasal Polyps | 2 | 2010 | 50 | 0.070 |
Why?
| | Papillomavirus Infections | 1 | 2008 | 264 | 0.070 |
Why?
| | Salivary Gland Diseases | 1 | 2004 | 3 | 0.070 |
Why?
| | Positive-Pressure Respiration | 1 | 2005 | 73 | 0.070 |
Why?
| | Neoplasm Invasiveness | 4 | 2000 | 456 | 0.070 |
Why?
| | Reproducibility of Results | 2 | 2012 | 2948 | 0.060 |
Why?
| | Neck | 2 | 2008 | 87 | 0.060 |
Why?
| | Coronary Artery Bypass | 2 | 2007 | 262 | 0.060 |
Why?
| | Tomography, X-Ray Computed | 4 | 2018 | 2462 | 0.060 |
Why?
| | Intubation, Intratracheal | 1 | 2005 | 193 | 0.060 |
Why?
| | Syndrome | 1 | 2022 | 352 | 0.050 |
Why?
| | Body Fluids | 1 | 2001 | 66 | 0.050 |
Why?
| | Acoustics | 1 | 2001 | 57 | 0.050 |
Why?
| | Sufentanil | 1 | 2000 | 1 | 0.050 |
Why?
| | Orbital Neoplasms | 1 | 2000 | 22 | 0.050 |
Why?
| | Survival Rate | 3 | 2007 | 1807 | 0.050 |
Why?
| | Airway Management | 1 | 2020 | 49 | 0.050 |
Why?
| | In Situ Hybridization | 1 | 2000 | 317 | 0.050 |
Why?
| | Semiconductors | 1 | 2000 | 37 | 0.050 |
Why?
| | Ethmoid Sinus | 1 | 1999 | 8 | 0.050 |
Why?
| | International Cooperation | 1 | 2020 | 181 | 0.050 |
Why?
| | Sphenoid Sinus | 1 | 1999 | 9 | 0.050 |
Why?
| | Neoplasm Staging | 3 | 1999 | 1215 | 0.050 |
Why?
| | Comparative Effectiveness Research | 1 | 2020 | 140 | 0.050 |
Why?
| | Image Enhancement | 3 | 2012 | 209 | 0.050 |
Why?
| | Retreatment | 1 | 2019 | 71 | 0.050 |
Why?
| | Preoperative Care | 2 | 2018 | 323 | 0.050 |
Why?
| | Anesthesia, Intravenous | 1 | 1999 | 12 | 0.050 |
Why?
| | Nasal Cavity | 1 | 1999 | 49 | 0.050 |
Why?
| | Critical Pathways | 1 | 1999 | 69 | 0.050 |
Why?
| | Oropharynx | 1 | 2019 | 37 | 0.040 |
Why?
| | Neoplasms, Multiple Primary | 1 | 1999 | 55 | 0.040 |
Why?
| | Craniotomy | 1 | 1999 | 70 | 0.040 |
Why?
| | Hearing Loss, Sensorineural | 1 | 1999 | 60 | 0.040 |
Why?
| | Patient Reported Outcome Measures | 1 | 2020 | 233 | 0.040 |
Why?
| | Pharyngeal Neoplasms | 1 | 1998 | 5 | 0.040 |
Why?
| | Meningioma | 1 | 1999 | 70 | 0.040 |
Why?
| | Virtual Reality | 1 | 2019 | 42 | 0.040 |
Why?
| | United States | 3 | 2020 | 12768 | 0.040 |
Why?
| | Adjuvants, Anesthesia | 1 | 1997 | 10 | 0.040 |
Why?
| | Asthma | 1 | 2011 | 2016 | 0.040 |
Why?
| | Laryngeal Diseases | 1 | 1997 | 22 | 0.040 |
Why?
| | Hemostasis, Surgical | 1 | 1997 | 24 | 0.040 |
Why?
| | Antiemetics | 1 | 1997 | 33 | 0.040 |
Why?
| | Lidocaine | 1 | 1997 | 46 | 0.040 |
Why?
| | Tongue Neoplasms | 1 | 1997 | 21 | 0.040 |
Why?
| | Anesthesia, General | 1 | 1997 | 46 | 0.040 |
Why?
| | Thyroid Cartilage | 1 | 1997 | 4 | 0.040 |
Why?
| | Laryngeal Mucosa | 1 | 1997 | 7 | 0.040 |
Why?
| | Elastic Tissue | 1 | 1997 | 9 | 0.040 |
Why?
| | Nausea | 1 | 1997 | 108 | 0.040 |
Why?
| | Fentanyl | 1 | 1997 | 64 | 0.040 |
Why?
| | Laryngectomy | 1 | 1997 | 17 | 0.040 |
Why?
| | Blood Loss, Surgical | 1 | 1997 | 84 | 0.040 |
Why?
| | Vomiting | 1 | 1997 | 124 | 0.040 |
Why?
| | Ligaments | 1 | 1997 | 41 | 0.040 |
Why?
| | Anesthetics, Local | 1 | 1997 | 88 | 0.040 |
Why?
| | Wound Closure Techniques | 1 | 2016 | 10 | 0.040 |
Why?
| | Betacoronavirus | 1 | 2020 | 268 | 0.040 |
Why?
| | Hypnotics and Sedatives | 1 | 1997 | 135 | 0.040 |
Why?
| | Intraoperative Complications | 1 | 1997 | 127 | 0.040 |
Why?
| | Endolymphatic Sac | 1 | 1996 | 1 | 0.040 |
Why?
| | Cochlear Nerve | 1 | 1996 | 8 | 0.040 |
Why?
| | Audiometry, Pure-Tone | 1 | 1996 | 24 | 0.040 |
Why?
| | Length of Stay | 2 | 2014 | 1046 | 0.040 |
Why?
| | Pain, Postoperative | 1 | 1997 | 184 | 0.040 |
Why?
| | Ear, Inner | 1 | 1996 | 32 | 0.040 |
Why?
| | Arrhythmias, Cardiac | 1 | 1999 | 328 | 0.040 |
Why?
| | Sleep | 1 | 2022 | 772 | 0.040 |
Why?
| | Cross-Sectional Studies | 2 | 2020 | 4630 | 0.040 |
Why?
| | Safety | 1 | 1997 | 314 | 0.040 |
Why?
| | Cocaine | 1 | 1997 | 168 | 0.040 |
Why?
| | Ventricular Dysfunction, Left | 1 | 1999 | 398 | 0.030 |
Why?
| | Pain Measurement | 1 | 1997 | 527 | 0.030 |
Why?
| | Cause of Death | 1 | 1997 | 399 | 0.030 |
Why?
| | Ear | 1 | 2014 | 30 | 0.030 |
Why?
| | Burnout, Professional | 1 | 2020 | 311 | 0.030 |
Why?
| | Speech Perception | 1 | 1996 | 88 | 0.030 |
Why?
| | Nasal Obstruction | 2 | 2008 | 25 | 0.030 |
Why?
| | Deafness | 1 | 1996 | 89 | 0.030 |
Why?
| | Ion Channels | 1 | 2014 | 131 | 0.030 |
Why?
| | Sex Factors | 1 | 2020 | 1918 | 0.030 |
Why?
| | Monitoring, Intraoperative | 2 | 2007 | 36 | 0.030 |
Why?
| | Surgical Wound Infection | 1 | 2016 | 216 | 0.030 |
Why?
| | Calcium Channels | 1 | 2014 | 161 | 0.030 |
Why?
| | Guidelines as Topic | 1 | 1996 | 281 | 0.030 |
Why?
| | Contrast Media | 2 | 2012 | 427 | 0.030 |
Why?
| | Anxiety | 1 | 2020 | 867 | 0.030 |
Why?
| | Logistic Models | 1 | 2019 | 2018 | 0.030 |
Why?
| | Sensitivity and Specificity | 3 | 2007 | 1897 | 0.030 |
Why?
| | Echo-Planar Imaging | 1 | 2012 | 21 | 0.030 |
Why?
| | Benchmarking | 1 | 2014 | 167 | 0.030 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2018 | 1209 | 0.030 |
Why?
| | Adenocarcinoma | 1 | 1999 | 818 | 0.030 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2014 | 483 | 0.030 |
Why?
| | Gadolinium | 1 | 2012 | 82 | 0.030 |
Why?
| | Pandemics | 1 | 2020 | 1155 | 0.030 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2012 | 84 | 0.030 |
Why?
| | Observer Variation | 1 | 2012 | 326 | 0.030 |
Why?
| | Pain | 1 | 1997 | 796 | 0.030 |
Why?
| | Depression | 1 | 2020 | 1196 | 0.030 |
Why?
| | Stress, Psychological | 1 | 2020 | 1149 | 0.030 |
Why?
| | Combined Modality Therapy | 2 | 2008 | 1191 | 0.030 |
Why?
| | Incidence | 1 | 1997 | 2504 | 0.020 |
Why?
| | Administration, Intranasal | 1 | 2010 | 86 | 0.020 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2012 | 283 | 0.020 |
Why?
| | Therapeutic Irrigation | 1 | 2010 | 70 | 0.020 |
Why?
| | Risk Factors | 4 | 2011 | 9124 | 0.020 |
Why?
| | Thyroidectomy | 1 | 2008 | 49 | 0.020 |
Why?
| | Reoperation | 1 | 2011 | 554 | 0.020 |
Why?
| | Nasal Septum | 1 | 2008 | 16 | 0.020 |
Why?
| | Microbiota | 1 | 2014 | 538 | 0.020 |
Why?
| | Iodine Radioisotopes | 1 | 2008 | 124 | 0.020 |
Why?
| | Debridement | 1 | 2008 | 92 | 0.020 |
Why?
| | Pituitary-Adrenal System | 1 | 2010 | 195 | 0.020 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2012 | 733 | 0.020 |
Why?
| | Intra-Aortic Balloon Pumping | 1 | 2007 | 25 | 0.020 |
Why?
| | Lymphatic Metastasis | 1 | 2008 | 303 | 0.020 |
Why?
| | Volatilization | 1 | 2007 | 61 | 0.020 |
Why?
| | Catecholamines | 1 | 2007 | 119 | 0.020 |
Why?
| | Hypothalamo-Hypophyseal System | 1 | 2010 | 270 | 0.020 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2014 | 1777 | 0.020 |
Why?
| | Shock, Cardiogenic | 1 | 2007 | 61 | 0.020 |
Why?
| | Principal Component Analysis | 1 | 2007 | 181 | 0.020 |
Why?
| | Recurrence | 1 | 2010 | 1009 | 0.020 |
Why?
| | Infusions, Intravenous | 1 | 2007 | 393 | 0.020 |
Why?
| | Emergencies | 1 | 2007 | 165 | 0.020 |
Why?
| | Adolescent | 2 | 2014 | 18902 | 0.020 |
Why?
| | Vascular Resistance | 1 | 2007 | 380 | 0.020 |
Why?
| | DNA, Viral | 1 | 2008 | 396 | 0.020 |
Why?
| | Discriminant Analysis | 1 | 2005 | 43 | 0.020 |
Why?
| | In Vitro Techniques | 1 | 2007 | 1143 | 0.020 |
Why?
| | Adipose Tissue | 2 | 2000 | 665 | 0.020 |
Why?
| | Thorax | 1 | 2004 | 50 | 0.020 |
Why?
| | Hemodynamics | 2 | 2000 | 1085 | 0.020 |
Why?
| | Acute Disease | 1 | 2007 | 983 | 0.020 |
Why?
| | Biopsy | 1 | 2008 | 1070 | 0.020 |
Why?
| | Endocarditis | 1 | 2004 | 38 | 0.020 |
Why?
| | Heart Rate | 1 | 2007 | 788 | 0.020 |
Why?
| | Heart Valve Diseases | 1 | 2004 | 182 | 0.010 |
Why?
| | Intensive Care Units | 1 | 2005 | 594 | 0.010 |
Why?
| | Lacrimal Apparatus Diseases | 1 | 2000 | 5 | 0.010 |
Why?
| | Intraoperative Care | 1 | 2000 | 44 | 0.010 |
Why?
| | Blood Pressure | 1 | 2007 | 1680 | 0.010 |
Why?
| | Oculomotor Muscles | 1 | 2000 | 39 | 0.010 |
Why?
| | Radiographic Image Enhancement | 1 | 2000 | 69 | 0.010 |
Why?
| | Infant | 1 | 1993 | 8255 | 0.010 |
Why?
| | Pennsylvania | 1 | 1999 | 114 | 0.010 |
Why?
| | Critical Care | 1 | 2004 | 519 | 0.010 |
Why?
| | Child, Preschool | 1 | 1993 | 9714 | 0.010 |
Why?
| | Dobutamine | 1 | 1999 | 37 | 0.010 |
Why?
| | Diagnostic Techniques, Surgical | 1 | 1998 | 1 | 0.010 |
Why?
| | Neck Muscles | 1 | 1998 | 12 | 0.010 |
Why?
| | Fascia | 1 | 1998 | 16 | 0.010 |
Why?
| | Fasciotomy | 1 | 1998 | 18 | 0.010 |
Why?
| | Health Resources | 1 | 1999 | 136 | 0.010 |
Why?
| | Forecasting | 1 | 2000 | 371 | 0.010 |
Why?
| | Gadolinium DTPA | 1 | 1998 | 56 | 0.010 |
Why?
| | Cardiotonic Agents | 1 | 1999 | 139 | 0.010 |
Why?
| | Neck Dissection | 1 | 1997 | 9 | 0.010 |
Why?
| | Actuarial Analysis | 1 | 1997 | 34 | 0.010 |
Why?
| | Surgical Wound Dehiscence | 1 | 1997 | 19 | 0.010 |
Why?
| | Melanoma | 1 | 2004 | 703 | 0.010 |
Why?
| | Radiotherapy Dosage | 1 | 1997 | 245 | 0.010 |
Why?
| | Cervical Vertebrae | 1 | 1998 | 114 | 0.010 |
Why?
| | Gastrostomy | 1 | 1997 | 89 | 0.010 |
Why?
| | Skin Neoplasms | 1 | 2004 | 812 | 0.010 |
Why?
| | Treatment Failure | 1 | 1997 | 340 | 0.010 |
Why?
| | Tracheostomy | 1 | 1997 | 92 | 0.010 |
Why?
| | Radiotherapy | 1 | 1997 | 191 | 0.010 |
Why?
| | Enteral Nutrition | 1 | 1997 | 161 | 0.010 |
Why?
| | Disease-Free Survival | 1 | 1997 | 678 | 0.010 |
Why?
| | Prognosis | 1 | 1997 | 3549 | 0.010 |
Why?
|
|
Thaler's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|